Compounded Semaglutide

What Is Compounded Semaglutide?

Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist — a synthetic analog of a gut hormone naturally secreted after eating. In healthy weight regulation, GLP-1 signals the brain that the meal is complete, slows digestion, and moderates appetite. In people with obesity, this biological signaling is chronically blunted: hunger persists strongly regardless of recent food intake, making sustained caloric restriction feel like fighting biology rather than making choices. Semaglutide replaces and amplifies that missing signal at therapeutic levels.

Through Tmates telehealth, compounded semaglutide is available in both injectable (once weekly, subcutaneous) and oral (once daily tablet) formulations at the same $249/month flat rate — with all dosage tiers from 0.25mg through 2.4mg included at that same price. This is the same active molecule as brand-name Ozempic® and Wegovy®, prepared by licensed US compounding pharmacies. It is not an FDA-approved finished product — Tmates discloses this clearly and provides a Wegovy® prescription management service at $99/mo for patients who specifically want the FDA-approved branded option.

At $249/month, compounded semaglutide through Tmates costs approximately 82% less than uninsured brand-name Wegovy® ($1,350+/month at retail), with equivalent pharmacological action. The savings reflect the difference in regulatory pathway, not in the active ingredient itself. For patients who understand this distinction and want clinically significant weight loss at an accessible price, compounded semaglutide through the Tmates weight loss category represents exceptional value.

Clinical Evidence: The STEP Trial Program

Semaglutide's weight loss evidence base is among the most extensive of any medication in recent clinical history. The STEP (Semaglutide Treatment Effect in People with Obesity) trial program produced landmark results that fundamentally changed what physicians and patients expected from pharmacological weight management:

• STEP-1 (NEJM, 2021): 1,961 adults with obesity taking semaglutide 2.4mg weekly achieved an average 14.9% body weight reduction over 68 weeks. 86.4% of participants achieved ≥5% weight loss; 69.1% achieved ≥10%; 50.5% achieved ≥15%. For a 250-pound patient, the average loss was approximately 37 pounds.
• STEP-3 (JAMA, 2021): Combined with intensive behavioral therapy, semaglutide produced 16.0% average weight loss at 68 weeks — demonstrating additive effects when medication is combined with structured lifestyle support.
• STEP-5 (Lancet, 2021): 104-week (2-year) data confirmed durability: sustained 15.2% average weight loss with continued treatment, showing that results hold when patients remain on medication.
• SELECT (NEJM, 2023): Beyond weight loss, semaglutide reduced major adverse cardiovascular events — heart attacks, strokes, cardiovascular death — by 20% in overweight adults without diabetes. This cardioprotective benefit emerged independent of the degree of weight loss, suggesting direct vascular mechanisms.

These results represent the strongest long-term pharmacological weight loss outcomes in clinical literature prior to tirzepatide. Compare semaglutide and tirzepatide head-to-head in our complete semaglutide vs tirzepatide comparison, or read our semaglutide vs phentermine comparison if you're considering the most affordable alternative.

What the Semaglutide Experience Feels Like

Understanding what patients actually experience on semaglutide helps set realistic expectations and prepare for the adjustment period. The most commonly reported — and most life-changing — effect isn't the scale number. It's the elimination of "food noise": the constant mental preoccupation with eating, cravings, and the next meal that people with obesity describe as a persistent background hum in their consciousness. Most semaglutide patients describe this noise quieting dramatically within 2–4 weeks of starting treatment. Eating appropriate portions feels natural rather than effortful. The urge to snack, overeat, or choose high-calorie foods diminishes without active willpower investment. This is the mechanism that makes sustained GLP-1 results possible — addressing the biology, not the behavior.

Nausea is the primary side effect to anticipate, particularly during the first 4–8 weeks and whenever the dose increases. Eating smaller, lower-fat meals; avoiding greasy foods; staying well-hydrated; and not eating immediately before or after injection all help manage this. For most patients, nausea diminishes significantly as the body adapts. Constipation is also common and typically managed with adequate hydration and fiber intake. If side effects are severe at any point, your Tmates physician can temporarily pause the dose increase or reduce the current dose — titration flexibility is built into every program.

Injectable vs Oral Semaglutide: Which Is Right for You?

Tmates offers both injectable (subcutaneous, once weekly) and oral (daily tablet) semaglutide at the same $249/month price — a meaningful flexibility advantage over platforms that offer only one format. Injectable semaglutide delivers the medication directly into subcutaneous tissue with highly consistent absorption and predictable bioavailability — this is the format used in all major clinical trials. A single weekly injection to the abdomen or thigh takes seconds. Oral semaglutide provides equivalent mechanism through the digestive route, though absorption is lower and more variable depending on timing relative to food and water intake (oral semaglutide should be taken with 4oz of water at least 30 minutes before the first food or drink of the day). For patients who are very uncomfortable with injections, oral is a clinically reasonable alternative. For patients seeking maximum, most consistent results, injectable is the clinically superior choice. Your Tmates physician will advise which format suits your situation and preferences — and format can be changed if needed.

Choose Your Plan

All plans include medication, physician consultations, ongoing support and free shipping. GLP-1 plans include all dosages at the same price — no upcharges during titration.

What Is Included

• ✓Personalized weight loss plan tailored to your starting weight, health history, and goals
• ✓GLP-1 receptor agonism — directly regulates appetite centers and eliminates food noise
• ✓Slows gastric emptying — food stays in stomach longer, extending satiety after meals
• ✓Once-weekly injectable or daily oral option — same $249/mo price for both formats
• ✓All dosage tiers from 0.25mg through 2.4mg at one flat monthly rate — no upcharges during titration
• ✓Free shipping from a licensed US compounding pharmacy on every order
• ✓Ongoing physician check-ins and dose adjustments throughout your program
• ✓Nutrition and lifestyle coaching included with weight loss programs

Possible Side Effects

Side effects are typically mild and temporary, particularly during the first 4–8 weeks of treatment while the body adjusts. Tmates physicians monitor your progress and can slow titration or adjust dosing if side effects are significant. The gradual titration schedule specifically minimizes side effect intensity during the adjustment period.

• Nausea — most common, especially during dose escalation; typically subsides after 4–8 weeks
• Constipation or mild diarrhea during the adjustment period
• Mild injection site reactions — redness or brief swelling at injection site
• Decreased appetite (the intended and primary mechanism of action)
• Fatigue during the first few weeks of treatment

How to Get Started

1. Complete the 90-second online intake at Tmates — covers health history, current medications, goals, and eligibility screening from any device
2. Licensed US physician reviews your case individually — board-certified doctor in your state, not automated approval; decision typically within 24 hours
3. Receive your personalized treatment plan — specific starting dose, titration schedule, dosing instructions, and administration guidance from your physician
4. Free delivery from a licensed US pharmacy — medication ships directly to your door; most patients receive their first order within 5–7 business days
5. Ongoing support and dose adjustment — your Tmates physician monitors progress and adjusts treatment as your response develops

Explore the Full Weight Loss Category

Tmates' Weight Loss category includes Compounded Semaglutide and other prescription options reviewed and prescribed by licensed US physicians. Browse the complete Tmates treatment catalog across all five categories. See also how the Tmates program works and read patient reviews.